US OptionsDetailed Quotes
MNMD241115P13000
- 0.00
- 0.000.00%
15min DelayTrading Nov 8 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest13.00Strike Price0.00Turnover0.00%IV-53.30%PremiumNov 15, 2024Expiry Date4.52Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.68Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Mind Medicine Stock Discussion
Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
$Mind Medicine (MNMD.US)$
$36 target!!!!!
https://www.moomoo.com/news/post/41181597/roth-mkm-initiates-mind-medicine-mnmdus-with-buy-rating-announces?futusource=news_stock_stockpagenews&ns_stock_id=37125992&report_id=37125992&report_type=stock&src=2&main_broker=WzEwMDdd&client_hour_clock=24&us_cid=73925127&channel=4&skintype=3&level=2&global_content={%22promote_content%22:%22mm:post:41181597%22,%22invite%22:73925127}&data_ticket=1721821266767476
$36 target!?!?
https://www.moomoo.com/news/post/41181597?futusource=news_stock_stockpagenews&ns_stock_id=37125992&report_id=37125992&report_type=stock&src=2&main_broker=WzEwMDdd&client_hour_clock=24&us_cid=73925127&channel=4&skintype=3&level=1&global_content=%7B%22promote_content%22%3A%22mm%3Apost%3A41181597%22%2C%22invite%22%3A73925127%7D&data_ticket=d852726825d53ffa91432d8eef415178
A small position however, it isn't showing up on the ticker at all!
https://www.fda.gov/news-events/press-announcements/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs
MindMed Announces Issuance of New Patent for Mm120 Orally Disintegrating Tablet (Odt)
MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)
MindMed (NASDAQ: MNMD) has been granted a new patent by the USPTO for its MM120 (lysergide) orally disintegrating tablet (ODT) formulation. This patent, extending protection until 2041, covers the pharmaceutical formulation, manufacturing methods, and treatment applications for MM120 ODT. The formulation incorporates Catalent's Zydis® ODT technology, which MindMed believes will offe...
No comment yet